由布拉迪基尼尼尼产生的冠状动脉血管扩张的机制
L R Pelc1, G J Gross, D C Warltier
1Department of Anesthesiology, Medical College of Wisconsin, Milwaukee 53226.
Circulation
|June 1, 1991
概括
布拉迪基宁通过激活B2受体和释放内皮衍生的放松因子来增加血液流向心脏的下内心脏,这是冠状动脉循环研究的一个关键发现.
科学领域:
- 心血管生理学心血管生理学
- 血管生物学 血管生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 布拉迪基宁是大脑循环中已知的血管扩张剂.
- 它对犬冠状动脉循环中的区域输液的影响以前没有研究过.
研究的目的:
- 为了研究布拉迪基宁诱导的冠状动脉血管扩张的机制.
- 确定循环氧化酶,布拉迪基宁B2受体和内皮衍生放松因子 (EDRF) 的作用.
主要方法:
- 在麻醉狗的冠状动脉内布拉迪基宁输液,以隔离对冠状动脉流动的影响.
- 使用放射性微球来测量区域血流量.
- 药理干预措施:印梅他辛,B2受体对抗剂,EDRF抑制剂 (奎纳克林,L-阿尔金因).
主要成果:
- 布拉迪基宁优先增加了心下内脏血流.
- 阻断B2受体减弱了布拉迪基宁对流动和分布的影响.
- 抑制EDRF降低了总流量,并阻止了心下内脏再分配.
结论:
- 冠内勃拉迪基宁可以增强心下输液.
- 这种效应是由B2受体刺激和EDRF释放,可能是氧化介导的.
相关概念视频
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...


